Does Lacosamide Lower Blood Pressure Significantly?
No, lacosamide (Vimpat) does not lower blood pressure significantly. Clinical trials and post-marketing data show no consistent hypotensive effect at therapeutic doses (200-400 mg/day). Blood pressure changes, if any, are minor and not clinically meaningful.[1][2]
What Do Clinical Studies Show on Blood Pressure?
In pivotal trials for epilepsy (SP667, SP754, SP755), mean systolic blood pressure dropped by 1-2 mmHg and diastolic by less than 1 mmHg versus placebo—within normal variability and not statistically significant for hypotension. No dose-response link to BP reduction appeared.[3][4]
Are There Reports of Low Blood Pressure as a Side Effect?
Hypotension is rare (<1% incidence) and typically tied to IV administration at high speeds (>2 mg/kg/min) or in patients with heart conditions. Oral use shows no signal in FDA adverse event reports or EMA data. Atrial fibrillation/flutter risks exist but don't involve BP drops.[1][5]
Who Might Experience Blood Pressure Changes?
Patients with dehydration, autonomic dysfunction, or on antihypertensives could see amplified effects, but lacosamide itself isn't causal. Orthostatic hypotension occurs in <0.5% of cases, often resolving without intervention.[2][6]
How Does Lacosamide Affect the Heart Overall?
It blocks sodium channels, slowing conduction and prolonging PR interval (dose-related, >10 ms in 10-20% of patients). This can cause bradycardia (heart rate <60 bpm in 1-5%) but not hypotension. ECG monitoring is advised for cardiac risks, not BP.[3][7]
[1]: FDA Vimpat Label
[2]: Drugs.com Lacosamide Side Effects
[3]: Biton V et al. Epilepsia 2008;49:1651-1660 (SP667 trial)
[4]: Chung WH et al. Epilepsia 2010;51:857-865 (SP754/SP755)
[5]: EMA Vimpat Summary
[6]: Harden CL. Ther Adv Neurol Disord 2016;9:308-318
[7]: Steinmaier J et al. Clin Pharmacol Ther 2016;99:422-430